麒麟控股前三季度业绩亮眼：净利润同比激增近30%，战略转型成效显著

Core Insights - Kirin Holdings reported strong financial performance for the first nine months of fiscal year 2025, with revenue of 1,756.12 billion yen (approximately 11.3 billion USD), a year-on-year increase of 3.3%, and operating profit of 170.54 billion yen, up 5.2%. Notably, net profit attributable to the parent company surged by 29.7% to 102.83 billion yen, exceeding market expectations [1] Group 1: Business Growth Drivers - The revenue growth of Kirin Holdings is primarily driven by two key pillars: the beer business and the health science business [2] - In the beer segment, Kirin, as the leader in the Japanese beer market, has strengthened its position through product premiumization and channel optimization, with flagship brand "Ichiban Shibori" seeing steady sales growth domestically and a 6% increase in international revenue, particularly in Southeast Asia [2] - The health science segment, focusing on functional beverages and probiotics, has become a new growth driver, with the subsidiary FANCL achieving a 12% revenue increase, contributing over 20% to the group's profits [2] Group 2: Cost Control and Profitability - Despite ongoing pressure from raw material costs and logistics expenses, Kirin has effectively mitigated these challenges through supply chain optimization and digital transformation, resulting in a 0.8 percentage point decrease in sales expense ratio and a 0.5 percentage point decrease in management expense ratio [3] - The overall gross margin improved to 38.7% from 37.2% in the previous year, aided by an increase in the proportion of high-margin health products [3] - The depreciation of the yen has also positively impacted export business, further enhancing overseas profits [3] Group 3: Strategic Acquisitions and Globalization - Kirin's globalization strategy has deepened with two significant acquisitions during the reporting period: a 30% stake in the Vietnamese craft beer brand "Bia Saigon" to strengthen its position in the Southeast Asian beer market, and an increase to 51% ownership in the Australian probiotic research company "BioGaia" to solidify its leadership in microbiome health technology [4] - The management has indicated a focus on the "Asian Growth Corridor" strategy, aiming to leverage Japan as a research center and rapidly penetrate emerging markets like Southeast Asia and India through acquisitions and localized production, with health science revenue expected to reach 40% by 2030 [4] Group 4: Market Outlook - Despite strong performance, Kirin faces challenges such as the long-term decline of the domestic beer market, global supply chain volatility, and intensified competition in the health science sector [5] - The company plans to address these challenges through product innovation, including increased development of non-alcoholic beers and functional beverages, enhancing its sustainable brand image with carbon-neutral beer production lines, and collaborating with top research institutions to deepen studies in microbiome and precision nutrition [5] Conclusion - Kirin Holdings' performance in the first three quarters of fiscal year 2025 validates the effectiveness of its "beer + health" dual-drive strategy, showcasing the resilience of traditional consumer giants amid transformation waves. With ongoing globalization and premiumization efforts, the century-old company is poised to create a second growth curve, demonstrating long-term value potential for global investors [6]